The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-0033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phosphoinositide-3 Kinase/Protein Kinase-B/Mammalian Target of Rapamycin Pathway in Psoriasis Pathogenesis. A Potential Therapeutic Target?

Acta Dermato-Venereologica
DermatologyMedicine
2014English

Phosphatidylinositol-3-Kinase Pathway

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

The Roles of Protein Kinase R in Cancer: Potential as a Therapeutic Target

Cancer Science
Cancer ResearchMedicineOncology
2018English

Transgelin in Bladder Cancer: A Potential Biomarker and Therapeutic Target

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Phosphatidylinositol 3-Kinase-Δ (PI3K-δ) Is a Potential Therapeutic Target in Adult T-Cell Leukemia-Lymphoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

EGFR Family Inhibition Identifies P38 MAPK as a Potential Therapeutic Target in Bladder Cancer

Urology
Urology
2018English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy